Plasma carotenoids, vitamin C, retinol and tocopherols levels and pancreatic cancer risk within the E uropean P rospective I nvestigation into C ancer and N utrition: A nested case–control study
Year: 2014
Type: article
Study design: Observational Study
Abstract: Evidence of a protective effect of several antioxidants and other nutrients on pancreatic cancer risk is inconsistent. The aim of this study was to investigate the association for prediagnostic plasma levels of carotenoids, vitamin C, retinol and tocopherols with risk of pancreatic cancer in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC). 446 incident exocrine pancreatic cancer cases were matched to 446 controls by age at blood collection, study center, sex, date and time of blood collection, fasting status and hormone use. Plasma carotenoids (α- and β-carotene, lycopene, β-cryptoxanthin, canthaxanthin, zeaxanthin and lutein), α- and γ-tocopherol and retinol were measured by reverse phase high-performance liquid chromatography and plasma vitamin C by a colorimetric assay. Incidence rate ratios (IRRs) with 95% confidence intervals (95%CIs) for pancreatic cancer risk were estimated using a conditional logistic regression analysis, adjusted for smoking status, smoking duration and intensity, waist circumference, cotinine levels and diabetes status. Inverse associations with pancreatic cancer risk were found for plasma β-carotene (IRR highest vs. lowest quartile 0.52, 95%CI 0.31-0.88, p for trend = 0.02), zeaxanthin (IRR highest vs. lowest quartile 0.53, 95%CI 0.30-0.94, p for trend = 0.06) and α-tocopherol (IRR highest vs. lowest quartile 0.62, 95%CI 0.39-0.99, p for trend = 0.08. For α- and β-carotene, lutein, sum of carotenoids and γ-tocopherol, heterogeneity between geographical regions was observed. In conclusion, our results show that higher plasma concentrations of β-carotene, zeaxanthin and α-tocopherol may be inversely associated with risk of pancreatic cancer, but further studies are warranted.
Source: International Journal of Cancer
DOI: 10.1002/ijc.29175
Authors: Suzanne M. Jeurnink, Martine M. Ros, Max Leenders, Franzel J.B. van Duijnhoven, Peter D. Siersema, Eugene H.J.M. Jansen, Carla H. van Gils, Marije F. Bakker, Kim Overvad, Nina Roswall, Anne Tjønneland, Marie‐Christine Boutron‐Ruault, Antoine Racine, Claire Cadeau, Verena Grote, Rudolf Kaaks, Krasimira Aleksandrova, Heiner Boeing, Antonia Trichopoulou, Vasiliki Benetou, Elisavet Valanou, Domenico Palli, Vittorio Krogh, Paolo Vineis, Rosario Tumino, Amalia Mattiello, Elisabete Weiderpass, Guri Skeie, José María Huerta Castaño, Eric J. Duell, Aurelio Barricarte, Esther Molina‐Montes, Marcial Argüelles, Mire Dorronsoro, Dorthe Johansen, Björn Lindkvist, Malin Sund, Francesca L. Crowe, Kay‐Tee Khaw, Mazda Jenab, Veronika Fedirko, E. Riboli, H. B(as) Bueno‐de‐Mesquita
Institutions: University Medical Center Utrecht, National Institute for Public Health and the Environment, Wageningen University & Research, Aarhus University, Danish Cancer Society, Université Paris-Sud, Inserm, Centre de recherche en Epidémiologie et Santé des Populations, German Cancer Research Center, German Institute of Human Nutrition, National and Kapodistrian University of Athens, Hellenic Health Foundation, Istituto per lo Studio e la Prevenzione Oncologica, Fondazione IRCCS Istituto Nazionale dei Tumori, Italian institute for Genomic Medicine, Imperial College London, Azienda Usl 8 Arezzo, Federico II University Hospital, University of Naples Federico II, Karolinska Institutet, Cancer Registry of Norway, Folkhälsans Forskningscentrum, UiT The Arctic University of Norway, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, Andalusian School of Public Health, Gobierno del Principado de Asturias, Biogipuzkoa Health Research Institute, Skåne University Hospital, University of Gothenburg, Umeå University, University of Oxford, University of Cambridge, World Health Organization, Centre international de recherche sur le cancer
Language: English
Subfield: Biochemistry (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2026806410
